Article Details

ESMO 2024: Anlotinib and penpulimab gather attention in HCC with APOLLO results

Retrieved on: 2024-09-16 00:43:58

Tags for this article:

Click the tags to see associated articles and topics

ESMO 2024: Anlotinib and penpulimab gather attention in HCC with APOLLO results. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. CMP Corporation · MyData · CDM NV · Cassie · View all. This news ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo